ZIMVV ZIMVIE INC

ZimVie Announces Launch of Next-Generation TSX™ Implant in the United States

ZimVie Announces Launch of Next-Generation TSX™ Implant in the United States

Newest innovation in ZimVie’s digital dentistry platform is designed for immediacy and peri-implant health

WESTMINSTER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX Implant in the United States, the latest innovation in the company’s platform of surgical, restorative, and digital dentistry solutions. TSX Implants are designed for immediate extraction and loading protocols as well as placement predictability and primary stability in soft and dense bone. The TSX Implant incorporates features with more than two decades of real-world, clinical data to deliver peri-implant health, crestal bone maintenance, long-term osseointegration, and prosthetic stability.1-8, 11-13* Integrated with ZimVie’s end-to-end digital workflows and engineered with surgical and restorative versatility, the TSX Implant furthers ZimVie’s commitment to simplify procedures and optimize practice protocols.

The TSX Implant made its debut last week at the American Academy of Periodontology’s annual meeting in Phoenix, Arizona, and follows ZimVie’s joint launch of the T3® PRO Tapered Implant and Encode® Emergence Healing Abutment in June 2022.

“I am pleasantly surprised how easily the TSX Implants engaged at the apex in extraction sites and was excited to see 50 Ncm (newton centimeters) of torque using the new extraction protocol,” said Julius Bunek, DDS, MS, PLLC in Ann Arbor, Michigan. “Further, I was impressed with how well the implant followed the planned path of insertion and did not track off course. This implant’s compatibility with my existing surgical and prosthetic instrumentation along with the new design features are just some of the reasons I plan to use this system in my practice.”

The TSX Implant utilizes a contemporary hybrid of ZimVie’s proprietary dual acid-etched (DAE) and MTX™ surface technologies to balance peri-implant health needs in the coronal and sub-coronal regions.1-5, 11-13* Minimally rough coronal surfaces like DAE may lower the risk of biofilm formation and peri-implantitis while offering excellent osseointegration potential to maintain crestal bone.1-5, 10-13* Meanwhile, the subcoronal MTX surface offers high osteoconductive potential with over two decades of clinical success.7, 8*

In addition to advanced surface technology, the TSX Implant’s progressive threads and taper are designed to follow the patient’s prepared osteotomy and provide a precisely positioned and aesthetically restored implant with high primary stability.1, 9*

“We created the TSX Implant to improve patient experience and enhance clinicians’ confidence in successful procedures that can be delivered more efficiently,” said Indraneel Kanaglekar, SVP and President of ZimVie Dental. “We continue to invest in bringing new, innovative products to market that broaden our suite of digitally integrated, efficient, and versatile workflows designed to improve patient health and satisfaction.”

ZimVie’s next-generation implant is compatible with the Encode® Emergence 3-in-1 Healing Abutment, Impression Coping, and Scanbody System. To help the surgeon master immediate implants with greater efficiency and more predictability, the TSX Implant is surgically compatible with familiar soft and dense bone protocols, existing tools, and the company’s digital dentistry platform.

For more information on ZimVie Dental implants, suite of connected solutions, and continuing education, please visit .

About ZimVie

ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Media Contact Information:



ZimVie

Laura Driscoll •

(774) 284-1606



ZimVie

Allison Johnson •

(774) 266-8046

Investor Contact Information:

Gilmartin Group LLC

Marissa Bych •

* Pre-clinical studies may not be indicative of clinical performance.

Data on file.

2 Xuesong Wang, Olga Sanchez, Elnaz Ajami, Hai Bo Wen. Impact of Implant Surface Roughness on Pathogenic Bacterial Adhesion. Abstract N° EAO- 266. European Association for Osseointegration, Geneva 2022. Accepted for publication at COIR Special Issue.

3 Zetterqvist L, Feldman S, Rotter B, et al. A prospective, multicenter, randomized controlled 5-year study of hybrid and fully etched implants for the incidence of peri-implantitis. J Periodontol. 2010; 81:493-501.

Mendes VC, Moineddin R, Davies JE. Discrete calcium phosphate nanocrystalline deposition enhances osteoconduction on titanium-based implant surfaces. J Biomed Mater Res A. 2009; 90(2):577-85.

5 Davies JE, Ajami E, Moineddin R, Mendes VC. The roles of different scale ranges of surface implant topography on the stability of the bone/implant interface. Biomaterials 2013; 34:3535-35456.

Lazzara RJ, Porter SS. Platform switching: a new concept in implant dentistry for controlling post- restorative crestal bone levels. Int J Periodontics Restorative Dent 2006; 26(1):9-17.

Trisi P, Marcato C, Todisco M. Bone-to-implant apposition with machined and MTX microtextured implant surfaces in human sinus grafts. Int J Periodontics Restorative Dent 2003; 23(5): 427-437.

Todisco M, Trisi P. Histomorphometric evaluation of six dental implant surfaces after early loading in augmented human sinuses. J Oral Implantol. 2006;32(4):153-166.

Huang HL, Tsai MT, Su KC, Li YF, Hsu JT, Chang CH, Fuh LJ, Wu AY. Relation between initial implant stability quotient and bone-implant contact percentage: an in vitro model study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):e356-61.

1Subramani et al. Biofilm on dental implants: a review of the literature. Int J Oral Maxillofac Implants 2009; 24(4):616-26.

1Park SJ, Sanchez O, Ajami E, Wen HB. Bacterial Adhesion to Different Dental Implant Collar Surfaces: An in-vitro comparative study. 34th Annual Meeting Academy of Osseointegration, Washington, DC, March 2019.

1Bermejo P, Sanchez MC, Llama-Palacios A, Figuero E, Herrera D, Sanz Alanso M. Biofilm formation on dental implants with different surface micro-topography: An in vitro study. Clin Oral Impl Res 2019; 30:725–734.

1Albrektsson T, Wennerberg A. Oral Implant Surfaces: Part 1-Review Focusing on Topographic and Chemical Properties of Different Surfaces and In Vivo Responses to Them. Int J Prosthodont 2004; 17(5):536-543.



EN
03/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE

ZimVie Reports Second Quarter 2025 Financial Results

ZimVie Reports Second Quarter 2025 Financial Results Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) million; Net Loss margin of (3.3)% Adjusted EBITDA[1] from Continuing Operations of $17.5 million; Adjusted EBITDA[1] margin of 15.0%GAAP diluted EPS from Continuing Operations of $(0.14) and adjusted diluted EPS[1] from Continuing Operations of $0.26 PALM BEACH GARDENS, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a g...

 PRESS RELEASE

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 202...

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July 30, 2025. On July 21, 2025, ZimVie issued a press release announcing ZimVie’s entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”) for $19.00 in cash pe...

 PRESS RELEASE

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant ...

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China Strategic Partnership Provides Market Presence in Growing Chinese Market PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s ...

 PRESS RELEASE

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $...

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash Transaction expected to close by year-end 2025 PALM BEACH GARDENS, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in...

 PRESS RELEASE

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite an...

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care PALM BEACH GARDENS, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its RealGUIDE® Software Suite and Implant Concierge® service in Japan. The launch of RealGUIDE and Implant Concierge in Japan expands dentists’ access to a unique digital dental implant ecosy...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch